Inherited chromosomally integrated Human herpesvirus 6 in patients with blood system diseases
https://doi.org/10.35754/0234-5730-2025-70-1-40-50
Abstract
Introduction. Human herpesvirus 6 (HHV-6) is an opportunistic agent causing various complications in patients with hematological diseases. The virus has a unique ability to integrate into telomeres of human chromosomes, which makes hereditary transmission of the viral genome possible. This form of the virus is called inherited chromosomally integrated HHV-6 (iciHHV-6). The iciHHV-6 frequency among patients with blood system diseases is unknown and its signifi cance for clinical practice remains insufficiently studied.
Aim — to determine the prevalence of ichHHV-6 in patients with hematological diseases.
Materials and methods. Clinical and laboratory data in 4,998 adult patients treated at the National Medical Research Center for Hematology (Moscow, Russia) from 2020 to 2024 were analyzed. Clinical materials obtained from patients were examined by molecular-biological methods for the presence of HHV-6 DNA.
Results. IciHHV-6 was confirmed in 14 out of 4,998 (0.26 %) enrolled patients. 5 patients (38,5 %) had clinical manifestations of herpesvirus infection during treatment, while the other 9 patients (61.5 %) showed no signs of the infection. 5 of 14 iciHHV-6-positive patients underwent hematopoietic stem cell transplantation. Criteria and laboratory tests for suspicion for iciHHV-6 were designed and successfully verified, which made it possible to suspect and prove the presence of hci-HCV-6.
Conclusion. The presence of ichHHV-6 among patients with hematological diseases was detected in 0.26 % of cases. The high concentration of HCV-6 DNA during polymerase chain reaction testing, as well as the absence of negative virological results during antiviral therapy, make it possible to suspect HCV-HCV-6. Screening for iciHHV-6 by qPCR of hair follicles and nails is recommended for patient with high viremia. A positive result in such tests confirms iciHHV-6-positive status. The efficiency of antiviral therapy in iciHHV-6-individuals requires further research. During transplantation of allogeneic hematopoietic stem cells to a recipient-carrier of hci-HCV-6, HCV-6 reactivation, asymptomatic persistence of high viremia, and a dramatic decrease of the viral load are all possible.
About the Authors
T. A. SoldatovaRussian Federation
Tatiana A. Soldatova, Clinical Laboratory Physician, Department of Blood Transfusion Infectious Safety
125167, Moscow
D. S. Tikhomirov
Russian Federation
Tatiana A. Soldatova, Clinical Laboratory Physician, Department of Blood Transfusion Infectious Safety
125167, Moscow
A. Yu. Krylova
Russian Federation
Dmitry S. Tikhomirov, Cand. Sci. (Biol.), Head of the Laboratory of Virology
125167, Moscow
E. N. Ignatova
Russian Federation
Elena N. Ignatova, Researcher
125167, Moscow
O. N. Misko
Russian Federation
Olga N. Misko, Biologist, Department of Blood Transfusion Infectious Safety
125167, Moscow
O. G. Starkova
Russian Federation
Oksana G. Starkova, clinical Laboratory physician, Department of Blood Transfusion Infectious Safety
125167, Moscow
A. V. Rekstyn
Russian Federation
Artem V. Rekstyn, medical receptionist, donor recruitment group
125167, Moscow
T. A. Tupoleva
Russian Federation
Tatiana A. Tupoleva, Dr. Sci. (Med.), Head of the Department of Blood Transfusion Infectious Safety
125167, Moscow
References
1. Kondo K., Kondo T., Okuno T., et al. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol. 1991; 72(6): 1401–8. DOI: 10.1099/0022-1317-72-6-1401.
2. Arbuckle J.H., Medveczky M.M., Luka J., et al. The latent human herpesvirus6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc Natl Acad Sci USA. 2010; 107(12): 5563–8. DOI: 10.1073/pnas.0913586107.
3. Yoshikawa T., Asano Y., Akimoto S., et al. Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis. J Med Virol. 2002; 66(4): 497–505.
4. Ahlqvist J., Fotheringham J., Akhyani N., et al. Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV6A in oligodendrocytes. J Neurovirol. 2005; 11(4): 384–94. DOI: 10.1080/13550280591002379.
5. Aimola G., Beythien G., Aswad A., Kaufer B.B. Current understanding of human herpesvirus 6 (HHV-6) chromosomal integration. Antiviral Res. 2020; 176: 104720. DOI: 10.1016/j.antiviral.2020.104720.
6. Shiohara T., Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)/ drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int. 2019; 68(3): 301–8. DOI: 10.1016/j.alit.2019.03.006.
7. Krichevskaya G.I. The Role of Human Herpesvirus-6 (HHV-6) in General Pathology and Ocular Inflammatory Disorders. Rossiyskiy oftalmolofgicheskiy zurnal. 2016; 9(1): 98–104 (In Russian). DOI: 10.21516/2072-0076-2016-9-1-98-104.
8. Hill J.A., Myerson D., Sedlak R.H., et al. Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature. Transpl Infect Dis. 2014; 16(3): 477–83. DOI: 10.1111/tid.12208.
9. Mysore K.R., Phan T.L., Himes R.W., et al. Human Herpesvirus 6 Infection in Pediatric Liver Transplantation: Single-Center Study of Incidence, Outcomes, and Management. J Pediatric Infect Dis Soc. 2021; 10(5): 599–606. DOI: 10.1093/jpids/piaa166.
10. de la Villa S., Catalina M.V., Conthe A. Fulminant HHV-6 hepatitis requiring liver transplantation. Transpl Infect Dis. 2022; 24(2): e13797. DOI: 10.1111/tid.13797.
11. Seyyedi N., Dehbidi G.R., Karimi M., et al. Human herpesvirus 6A active infection in patients with autoimmune Hashimoto’s thyroiditis. Braz J Infect Dis. 2019; 23(6): 435–40. DOI: 10.1016/j.bjid.2019.10.004.
12. Caselli E., Zatelli M.C., Rizzo R., et al. Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis. PLoS Pathog. 2012; 8(10): e1002951. DOI: 10.1371/journal.ppat.1002951.
13. Leibovitch E.C., Jacobson S. Evidence linking HHV-6 with multiple sclerosis: an update. Curr Opin Virol. 2014; 9: 127–33. DOI: 10.1016/j.coviro.2014.09.016.
14. Tarlinton R.E., Martynova E., Rizvanov A.A., et al. Role of Viruses in the Pathogenesis of Multiple Sclerosis. Viruses. 2020; 12(6): 643. DOI: 10.3390/v12060643.
15. Voumvourakis K.I., Fragkou P.C., Kitsos D.K., et al. Human herpesvirus 6 infection as a trigger of multiple sclerosis: an update of recent literature. BMC Neurol. 2022; 22(1): 57. DOI: 10.1186/s12883-022-02568-7.
16. Tikhomirov D.S., Garanzha T.A., Troitskaya V.V., et. al. Laboratory diagnosis of herpesvirus infections in patients with acute leukemias. Voprosy virusologii. 2009; 54(1): 19–21 (In Russian).
17. Arbuckle J.H., Pantry S.N., Medveczky M.M., et al. Mapping the telomere integrated genome of human herpesvirus 6A and 6B. Virology. 2013; 442(1): 3–11. DOI: 10.1016/j.virol.2013.03.030.
18. Kaufer B.B., Flamand L. Chromosomally integrated HHV-6: impact on virus, cell and organismal biology. Curr Opin Virol. 2014; 9: 111–8. DOI: 10.1016/j.coviro.2014.09.010.
19. Daibata M., Taguchi T., Nemoto Y., et al. Inheritance of chromosomally integrated human herpesvirus 6 DNA. Blood. 1999; 94(5): 1545–9.
20. Ward K.N., Leong H.N., Nacheva E.P., et al. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol. 2006; 44(4): 1571– 4. DOI: 10.11л/JCM.44.4.1571-1574.2006.
21. Gabrielli L., Balboni A., Borgatti E.C., et al. Inherited Chromosomally Integrated Human Herpesvirus 6: Laboratory and Clinical Features. Microorganisms. 2023; 11(3): 548. DOI: 10.3390/microorganisms11030548.
22. Strenger V., Caselli E., Lautenschlager I., et al. Detection of HHV-6-specific mRNA and antigens in PBMCs of individuals with chromosomally integrated HHV-6 (ciHHV-6). Clin Microbiol Infect. 2014; 20(10): 1027–32. DOI: 10.1111/1469-0691.12639.
23. Tanaka-Taya K., Sashihara J., Kurahashi H., et al. Human herpesvirus 6 (HHV6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol. 2004; 73(3): 465–73. DOI: 10.1002/jmv.20113.
24. Gravel A., Dubuc I., Morissette G., et al. Inherited chromosomally integrated human herpesvirus 6 as a predisposing risk factor for the development of angina pectoris. Proc Natl Acad Sci USA. 2015; 112(26): 8058–63. DOI: 10.1073/pnas.1502741112.
25. Domonova E.A., Silveistova O.Yu., Goptar I.A., et al. First data on the prevalence of inherited chromosomally integrated human Betaherpesvirus 6A/B in Russia. Epidemiologiya i infektsionnye bolezni. Aktual’nye voprosy. 2019; 9(4): 43–50 (In. Russian). DOI: 10.18565/epidem.2019.9.4.43-50.
26. Berneking L., Both A., Langebrake C., et al. Detection of human herpesvirus 6 DNA and chromosomal integration after allogeneic hematopoietic stem cell transplantation: A retrospective single center analysis. Transpl Infect Dis. 2022; 24(3): e13836. DOI: 10.1111/tid.13836.
27. Hubacek P., Hyncicova K., Muzikova K., et al. Disappearance of pre-existing high HHV-6 DNA load in blood after allogeneic SCT. Bone Marrow Transplant 2007; 40: 805–6. DOI: 10.1038/sj.bmt.1705813.
28. Miura H., Kawamura Y., Ohye T., et al. Inherited Chromosomally Integrated Human Herpesvirus 6 Is a Risk Factor for Spontaneous Abortion. J Infect Dis. 2021; 223(10): 1717–23. DOI: 10.1093/infdis/jiaa606.
Review
For citations:
Soldatova T.A., Tikhomirov D.S., Krylova A.Yu., Ignatova E.N., Misko O.N., Starkova O.G., Rekstyn A.V., Tupoleva T.A. Inherited chromosomally integrated Human herpesvirus 6 in patients with blood system diseases. Russian journal of hematology and transfusiology. 2025;70(1):40-50. (In Russ.) https://doi.org/10.35754/0234-5730-2025-70-1-40-50